Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Methanol | HCID 887 | — |
| Reactant | Water | HCID 962 | — |
| Reactant | Diisopropylethylamine | HCID 81531 | — |
| Reactant | 3,3-Difluoroazetidine hydrochloride | HCID 2758247 | — |
| Reactant | HCID 68688927 | HCID 68688927 | — |
| Catalyst | Titanium isopropoxide | HCID 11026 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | HCID 86633436 | HCID 86633436 | — |
Reaction Steps
To a solution of 6,7-dichloro-4-{4-fluoro-3-[(4-oxopiperidin-1-yl)carbonyl]benzyl}pyrrolo[1,2-a]pyrazin-1(2H)-one (Example 232, which was prepared as described in Example 13) (1 eq) in THF (0.6 M) were added titanium(IV) isopropoxide (1.6 eq), 3,3-difluoroazetidine hydrochloride (1.6 eq) and DIPEA (1.6 eq). The reaction mixture was stirred for 30 minutes at RT and then a solution of NaBH3(CN) (1.3 eq) in MeOH (0.16 M) was added. After 30 minutes water was added, and the resulting precipitate was filtered and washed with MeOH. The filtrate was evaporated and purified by RP-HPLC (column Symmetry RP 18, 7 μm, 19×300 mm, gradient A: H2O+0.1% TFA; B: MeCN+0.1% TFA) and the pooled fractions were evaporated under reduced pressure to yield the title compound. 1H NMR (300 MHz, DMSO-d6+TFA, 300K) δ 10.94-10.88 (1H, m), 7.38-7.10 (4H, m), 6.64-6.55 (1H, m), 4.91-4.78 (4H, m), 4.62-4.50 (1H, m), 4.44-4.25 (2H, m), 3.61-3.32 (2H, m), 3.10-2.90 (1H, m), 2.82-2.66 (1H, m), 2.10-1.72 (2H, m), 1.48-1.0 (2H, m). MS (ES+) C23H21Cl2F3N4O2 requires: 512/514, found: 513/515 (M+H)+.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07834015B2 |
|---|
| Source dataset | uspto-grants-2010_11 |
|---|
| ORD ID | ord-64ebebdbb7ea4b17a5e48410031e4ba9 |
|---|
| Source note | uspto-grants-2010_11 |
|---|